Ariana Boswell

Ariana Boswell received her bachelor's degree in biochemistry from Vassar College and is currently pursuing her Master of Public Health in epidemiology at Columbia University Mailman School of Public Health. She has previously conducted research on rare and chronic diseases at Vassar College and Yale School of Medicine and hopes to remain involved in rare disease research and communications in the future. Ariana joined Rare Disease Advisor in 2024.

All articles by Ariana Boswell

Combination treatment improves survival in cisplatin-eligible MIBC

Pembrolizumab and enfortumab vedotin reduce the risk of death, progression or recurrence in muscle invasive bladder cancer, Pfizer shared.
When to get a second opinion after a bladder cancer diagnosis

Whether you’ve just been diagnosed or have already undergone treatment, it’s never too late to think about seeking a second opinion.
Women may face worse outcomes after chemo-radiation for bladder cancer

Among patients receiving chemo-radiation for muscle-invasive bladder cancer, females had worse cancer-specific survival than males.
What is muscle-invasive bladder cancer?

About 25% of bladder cancer cases are muscle-invasive.

Ariana Boswell

All articles by Ariana Boswell

Combination treatment improves survival in cisplatin-eligible MIBC

When to get a second opinion after a bladder cancer diagnosis

Women may face worse outcomes after chemo-radiation for bladder cancer

What is muscle-invasive bladder cancer?